Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?

2015-04-01 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?​
Weber, M. S.​ (2015) 
Neurology® neuroimmunology & neuroinflammation, 2(2) art. e84​.​ DOI: https://doi.org/10.1212/NXI.0000000000000084 

Copy

Further links

Documents & Media

License

Published Version

Attribution-NonCommercial-NoDerivs 3.0 CC BY-NC-ND 3.0

Details

Authors
Weber, Martin S.
Abstract
not available
Issue Date
1-April-2015
Journal
Neurology® neuroimmunology & neuroinflammation 
Organization
Universitätsmedizin Göttingen
ISSN
2332-7812
Language
English

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media